MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.13M | -2.74M | -2.60M | -2.89M | -4.24M |
| Total Depreciation and Amortization | 36.10K | 36.10K | 38.60K | 43.70K | 48.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 422.20K | 630.40K | 20.50K | 841.70K | 1.45M |
| Change in Net Operating Assets | 587.10K | 343.30K | 469.40K | 1.06M | 1.17M |
| Cash from Operations | -2.08M | -1.73M | -2.07M | -941.30K | -1.57M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -5.00M | -- | -- | -- |
| Issuance of Common Stock | 1.37M | 3.15M | 1.35M | 13.55M | 500.00 |
| Repurchase of Common Stock | 0.00 | -251.80K | -173.40K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.37M | -2.10M | 1.18M | 13.55M | 500.00 |
| Foreign Exchange rate Adjustments | -2.00K | -1.20K | -22.20K | -5.00K | 15.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -718.70K | -3.83M | -920.90K | 12.60M | -1.55M |